Quasi‑meningitis (Aseptic Meningitis)
Overview
Quasi‑meningitis, more commonly referred to as aseptic meningitis, is an inflammation of the meninges—the protective membranes surrounding the brain and spinal cord—caused by non‑bacterial agents. The term “aseptic” indicates that standard bacterial cultures of the cerebrospinal fluid (CSF) are negative.
Most cases are self‑limited and resolve within a week to ten days, but the presentation can mimic bacterial meningitis, making accurate diagnosis essential.
Who it affects: Aseptic meningitis can occur at any age, but epidemiologic data show two peaks:
- Children and adolescents (especially under 5 years) – often linked to viral infections such as enteroviruses.
- Young adults (20‑40 years) – frequently associated with drug‑induced or autoimmune causes.
Prevalence: In the United States, aseptic meningitis accounts for roughly 2‑4 % of all meningitis hospitalizations, translating to an estimated 4,000–6,000 admissions annually (CDC). Worldwide, viral meningitis is the most common cause of meningitis, with incidence rates ranging from 10 to 30 per 100,000 population per year (WHO).
Symptoms
Symptoms usually appear 2‑10 days after the initial infection or exposure and can develop rapidly over several hours. The classic triad—headache, fever, and neck stiffness—may be present, but many patients experience additional signs:
General symptoms
- Fever – often low‑grade (38‑39 °C) but can exceed 40 °C.
- Headache – usually diffuse, worsens with movement, and may be described as “pressure‑like.”
- Neck stiffness (nuchal rigidity) – difficulty bending the neck forward.
- Photophobia – increased sensitivity to light.
- Phonophobia – sensitivity to sound.
Neurologic symptoms
- Mild confusion or lethargy – patients may appear “spacey” but usually remain oriented.
- Vomiting – often non‑bloody, related to increased intracranial pressure.
- Altered mental status – more common in immunocompromised or elderly patients.
Other possible manifestations
- Rash (especially with enteroviral or parechoviral infections).
- Arthralgia or myalgia (commonly with mumps, coxsackievirus, or drug‑induced cases).
- Urinary frequency or urgency (seen with some viral infections).
- Joint swelling (in cases linked to systemic lupus erythematosus or other autoimmune diseases).
Symptoms typically resolve within 7‑10 days without specific therapy, but persistent or worsening signs warrant urgent evaluation.
Causes and Risk Factors
Aseptic meningitis is a heterogeneous condition. The most common etiologies fall into three broad categories: viral, non‑viral infectious, and non‑infectious.
Viral (≈ 70‑80 % of cases)
- Enteroviruses – especially Coxsackievirus A9, Echovirus 9; responsible for > 50 % of viral meningitis in temperate climates (CDC).
- Herpesviridae – HSV‑2 (most common in sexually active adults), HSV‑1, Varicella‑zoster virus, Epstein‑Barr virus.
- Mumps virus – occasional in unvaccinated populations.
- Arboviruses – West Nile, La Crosse, St. Louis encephalitis (geographically limited).
- Other – Parechoviruses, Adenoviruses, Rabies (rare, but crucial to recognize).
Non‑viral infectious
- Mycobacteria (e.g., Mycobacterium tuberculosis) – usually classified as “culture‑negative” tuberculous meningitis.
- Fungal organisms – Cryptococcus, Histoplasma (especially in immunocompromised hosts).
- Parasites – Toxoplasma, Naegleria fowleri (rare but severe).
Non‑infectious (≈ 20‑30 % of cases)
- Drug‑induced – Nonsteroidal anti‑inflammatory drugs (NSAIDs), antibiotics (especially trimethoprim‑sulfamethoxazole), intravenous immunoglobulin, and vaccines (MMR, varicella).
- Autoimmune conditions – Systemic lupus erythematosus, Sjögren’s syndrome, Behçet’s disease.
- Neoplastic meningitis – Leptomeningeal spread of solid tumors or hematologic malignancies.
- Post‑infectious inflammatory response – Following a viral respiratory or gastrointestinal illness.
Risk factors
- Age < 5 years (enteroviral exposure in daycare settings).
- Immunosuppression (HIV, organ transplant, chemotherapy).
- Recent upper respiratory or gastrointestinal infection.
- Sexual activity with multiple partners (higher HSV‑2 risk).
- Recent vaccination or receipt of certain medications.
- Travel to endemic regions for arboviruses.
Diagnosis
Because clinical presentation overlaps with bacterial meningitis, a systematic approach is essential.
Initial evaluation
- Detailed history (exposures, recent illnesses, medication list, travel, immunization status).
- Complete neurologic examination (assessment for focal deficits, Kernig’s/Brudzinski’s signs).
- Vital signs – note fever, tachycardia, blood pressure, respiratory rate.
Laboratory and imaging studies
Lumbar puncture (LP) – cornerstone test
The CSF profile in aseptic meningitis typically shows:
- Opening pressure: Normal to mildly elevated (≤ 250 mm H₂O).
- White blood cell count: 10‑500 cells/µL, predominately lymphocytes (though neutrophil predominance can occur early).
- Protein: Mildly elevated (30‑100 mg/dL).
- Glucose: Normal (45‑80 mg/dL) or slightly low but > 40 % of serum glucose.
- Gram stain & bacterial culture: Negative.
- Viral PCR panel: Detects enteroviruses, HSV, VZV, CMV, and others with > 95 % sensitivity (Cleveland Clinic).
Blood tests
- Complete blood count (CBC) – often shows mild leukocytosis.
- Serum electrolytes & glucose – to compare with CSF glucose.
- Serologic testing for specific viruses (e.g., HSV IgM, mumps IgM) when PCR unavailable.
- Autoimmune panel (ANA, anti-dsDNA) if autoimmune meningitis is suspected.
Neuroimaging
- CT scan (non‑contrast) – performed before LP if signs of increased intracranial pressure, focal deficits, or immunocompromise exist.
- MRI with gadolinium – more sensitive for detecting meningeal enhancement, especially in viral, autoimmune, or neoplastic etiologies.
Diagnostic algorithm (simplified)
- Assess for red‑flag signs → immediate CT → start empirical antibiotics if bacterial meningitis cannot be excluded.
- Perform LP → analyze CSF.
- If CSF gram stain/culture negative and lymphocytic pleocytosis → send viral PCR panel.
- Tailor further testing based on epidemiology (e.g., arbovirus serology for travel history) and medication exposure.
Treatment Options
Management hinges on the underlying cause.
Supportive care (mainstay for most viral cases)
- Hydration – oral or intravenous fluids to maintain eu‑volemia.
- Antipyretics – acetaminophen or ibuprofen for fever and headache relief (avoid NSAIDs if drug‑induced meningitis is suspected).
- Rest and a quiet environment – reduces photophobia and head pain.
- Monitoring – regular neurochecks for any deterioration.
Antiviral therapy
- HSV‑2 or HSV‑1 meningitis: Acyclovir 10 mg/kg IV every 8 h for 10‑14 days (based on NIH guidelines).
- Varicella‑zoster meningitis: Acyclovir 10‑15 mg/kg IV q8h, then transition to oral valacyclovir.
- Enterovirus meningitis: No specific antiviral approved; supportive care is standard. Pleconaril has shown activity but is not FDA‑approved for meningitis.
- Rabies: Post‑exposure prophylaxis (HRIG + vaccine) must be initiated immediately; once symptoms develop, prognosis is uniformly fatal.
Management of non‑viral etiologies
- Drug‑induced aseptic meningitis: Immediate discontinuation of the offending agent; symptoms usually resolve within 48‑72 hours.
- Autoimmune meningitis: High‑dose corticosteroids (e.g., methylprednisolone 1 g IV daily for 3‑5 days) followed by a taper; immunosuppressants (azathioprine, mycophenolate) may be added for chronic disease.
- Neoplastic meningitis: Intrathecal chemotherapy (methotrexate, cytarabine) and/or radiation therapy, coordinated by oncology.
Hospitalization criteria
- Age < 2 years or immunocompromised status.
- Severe headache, vomiting, or altered mental status.
- Inability to maintain oral intake.
- Uncertain etiology pending CSF results.
Living with Quasi‑meningitis (aseptic meningitis)
Most patients recover fully, but a few may experience lingering symptoms.
Post‑infection fatigue and “brain fog”
- Gradual return to normal activities over 2‑4 weeks.
- Prioritize sleep hygiene (7‑9 hours/night) and balanced nutrition.
Pain management
- Acetaminophen is first‑line; avoid aspirin in children due to Reye’s syndrome risk.
- Short courses of low‑dose opioids are rarely needed and should be used under physician guidance.
When to follow up
- Neurology or infectious‑disease clinic within 1 week of discharge.
- Repeat lumbar puncture only if symptoms persist beyond 10 days or worsen.
- Vaccination updates (e.g., MMR, varicella) if the underlying cause was vaccine‑preventable.
Psychosocial considerations
- Educate family members that aseptic meningitis is rarely contagious (except for certain viral etiologies like enteroviruses). Emphasize hand‑washing and surface disinfection during outbreaks.
- Provide resources for anxiety or post‑viral fatigue, such as counseling or support groups.
Prevention
Because many triggers are infectious, prevention focuses on reducing exposure and strengthening immunity.
- Vaccination: MMR, varicella, and influenza vaccines dramatically lower the risk of viral meningitis (CDC).
- Hand hygiene: Frequent hand‑washing with soap for at least 20 seconds, especially after diaper changes or contact with respiratory secretions.
- Safe food & water: Properly cooking shellfish and avoiding untreated water reduces exposure to certain enteroviruses.
- Sexual health: Condom use and limiting the number of sexual partners lowers HSV‑2 transmission.
- Medication vigilance: Discuss any prior drug‑induced meningitis with pharmacists; consider alternative agents when possible.
- Avoiding mosquito bites in endemic areas (use EPA‑registered repellents, wear long sleeves).
Complications
Although most cases resolve without sequelae, complications can arise, especially when diagnosis or treatment is delayed.
- Neurologic deficits: Persistent headache, mild cognitive impairment, or focal deficits (rare).
- Hydrocephalus: Obstructive or communicating hydrocephalus may develop, requiring shunt placement.
- Seizures: Occur in up to 5 % of viral meningitis cases; most are self‑limiting but may necessitate antiepileptic therapy.
- Chronic meningitis: Seen with autoimmune or neoplastic causes; may require long‑term immunosuppression.
- Mortality: Extremely low (<1 %) for classic viral aseptic meningitis, but can approach 30 % in untreated tuberculous or fungal meningitis (NIH).
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you notice any of the following:
- Sudden onset of severe headache described as “worst ever.”
- Neck stiffness that prevents you from touching your chin to your chest.
- High fever (> 39.5 °C / 103 °F) that does not respond to antipyretics.
- New confusion, difficulty waking, or seizures.
- Vomiting more than three times in an hour or unable to keep fluids down.
- Rash that spreads quickly or looks petechial (tiny red spots).
- Rapid breathing, bluish lips or fingertips, or a fast heart rate (> 120 bpm).
These signs may indicate bacterial meningitis or a severe complication that requires immediate antibiotics, steroids, or neurosurgical intervention.
```